Company profile for Shift Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shift Bioscience focuses on cell rejuvenation to combat aging-related diseases using innovative AI and genetic interventions. Their research aims to reverse cellular aging without inducing stem cell characteristics, making breakthroughs in epigenetic rejuvenation. The company has developed an advanced platform for screening potential rejuvenation compounds and is led by a team of experts in aging research. Shift Bioscience is ...
Shift Bioscience focuses on cell rejuvenation to combat aging-related diseases using innovative AI and genetic interventions. Their research aims to reverse cellular aging without inducing stem cell characteristics, making breakthroughs in epigenetic rejuvenation. The company has developed an advanced platform for screening potential rejuvenation compounds and is led by a team of experts in aging research. Shift Bioscience is dedicated to pushing the boundaries of longevity science.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
The Gurdon Institute Tennis Court Road Cambridge CB2 1QN
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251111291289/en/Shift-Bioscience-Publishes-Improved-Metric-Calibration-Framework-for-Robust-Genetic-Perturbation-Modeling-Using-AI-Virtual-Cells

BUSINESSWIRE
11 Nov 2025

https://www.businesswire.com/news/home/20250520268201/en/Shift-Bioscience-Appoints-Lord-David-Prior-and-Sir-Tony-Kouzarides-to-Support-Long-Term-Strategy-for-Cell-Rejuvenation-Therapeutics

BUSINESSWIRE
20 May 2025

https://www.contractpharma.com/breaking-news/shift-bioscience-announces-board-and-advisor-appointments/

CONTRACTPHARMA
20 May 2025

https://www.businesswire.com/news/home/20250311855995/en

BUSINESSWIRE
12 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty